Boston Children's Hospital

Do you have an MD or MD/PhD and currently hold a postdoctoral research position at a Boston medical department, research institute, or academic institution? You could be eligible for the new Karp Family Foundation Early Career Award for Pediatric Brain Tumor Research through our Dana-Farber/Boston Children’s Brain Tumor Center. This award provides each of two outstanding early career investigators in pediatric oncology, neurosurgery, neurology, neuropathology, or radiation oncology with a $150,000 grant. Candidates must apply by September 15, 2025 🗓️ Learn more 👉 http://ms.spr.ly/6049seXIZ

Boston Children’s Hospital is proud to be represented at the upcoming Gene Therapy Summit (Sept. 10–11 in Boston). Our experts, including Christy Duncan, MD; Colleen Dansereau, MSN, RN, CPN; Alyce Norcross, MPH; and Donna Casey, SVP, will join colleagues from across the field to share insights on advancing gene therapy. We look forward to the meaningful collaboration that will help bring innovative therapies to children and families who need them most. Register today to join us: https://lnkd.in/ggMAUKTc

Join us for the first in-person Facing Heterotaxy Together conference, October 9-12, 2025, in Boston. 🗓️ This unique four-day event will bring together researchers, clinicians, advocates, and families to share knowledge, advance care, and strengthen the heterotaxy community. The clinician-focused portion — the Heterotaxy Research and Clinical Care Collaborative (HRC3) scientific conference — takes place October 10-11, featuring key topics including: • Innovations in cardiac surgery • Primary ciliary dyskinesia (PCD) • Immune dysregulation • Genetic assessment • GI and hepatic disease • Comprehensive multidisciplinary care • Current and future research 📍 Located at Marriott Courtyard Boston Downtown 🏥 Sponsored by Boston Children’s Benderson Family Heart Center 🤝 In partnership with HRC3 and HETEROTAXY CONNECTION Register now ➡️ http://ms.spr.ly/6043skqtz

“Rather than the clinician being with the patient in the operating room, you would have robots at the satellite hospitals, and the clinician could stay at the main hospital and connect remotely to perform procedures,” says Pierre Dupont about the future of medical robots. Learn more in this Harvard Medical School Gazette article. ⤵️

Children with the hereditary form of retinoblastoma, a rare childhood eye cancer, are at increased risk for developing intraocular disease, as well as other types of cancer — particularly sarcomas, brain tumors, and melanomas — throughout their life. To provide strategies for identifying and caring for patients with hereditary retinoblastoma, Junne Kamihara, MD, PhD, and her colleagues recently updated their recommendations as part of a series of consensus guidelines published by the American Association for Cancer Research’s Childhood Cancer Predisposition Workshop. The updates highlight an expanded focus on genetic testing for children with retinoblastoma and their families, an expanded discussion regarding screening recommendations for other cancers, and information for counseling of survivors of intraocular disease. ⤵️

Check out our own Dr. Wendy Chung, Chief of Pediatrics featured by RARE Revolution Magazine

Boston Children’s Hospital is hosting Single Ventricle Family Day on September 20 at the New England Aquarium! This free event offers opportunities for patients & families with single ventricle heart conditions to connect, learn from experts, and enjoy a day together in a supportive community setting. Family day is open to anyone with a single ventricle condition – not just Boston Children’s patients! Additional Ventures Mezzion 🔗🗓️ Learn more about the event and registration details here: http://ms.spr.ly/6042sVHeE

Many children in low-income countries receive limited heart care because cardiologists don’t have access to advanced diagnostic technology. A new Boston Children’s initiative hopes to change that by offering AI-powered diagnostic models to doctors everywhere. Read how they’ll do it. ⤵️

“We have to try to categorize people and understand the complexity, because that’s how we make progress,” says Chief of Clinical Enterprise Matthew Siegel, MD. Learn more about the research efforts to categorize Autism subtypes in The Transmitter ⤵️

In 2023, we performed the country’s first successful fetal embolization for vein of Galen malformation (VOGM), a new fetal surgical approach developed by our team. New results just published in JAMA build on that progress, showing continued promise from the ongoing trial: 📉 Reduced neonatal mortality from 90 to 43 percent ✔️ 3 of 5 treated patients show no neurodevelopmental delays On the significance of these findings, principal investigator, Darren Orbach, MD, PhD, says, “These early results demonstrate that fetal embolization is feasible, and show the importance of completing a clinical trial to really show that it is safe and effective.” As the study progresses, so does the potential to change outcomes for these high-risk patients: https://lnkd.in/ehVQVH5q